RATIONALE: Serotonin (5-hydroxytryptamine, 5-HT) is implicated in the aetiology and treatment of a variety of psychiatric disorders. A limitation of research has been the necessity to use indirect measures of 5-HT function. METHOD: We describe a method of analysing pharmacoMRI data using SPM and apply it to the direct i.v. infusion of selective 5-HT reuptake inhibitor, citalopram, in 12 healthy volunteers. Scanning took place on a 1.5-T Philips MRI scanner. RESULTS: Areas implicated in depression and its treatment were observed to have increasing signal with respect to time. These areas included the caudate, the amygdala, the hippocampus, the striatum and the thalamus. CONCLUSION: Direct pMRI using i.v. citalopram opens new ways of investigating 5-HT mechanism in depression and its treatment.
RATIONALE: Serotonin (5-hydroxytryptamine, 5-HT) is implicated in the aetiology and treatment of a variety of psychiatric disorders. A limitation of research has been the necessity to use indirect measures of 5-HT function. METHOD: We describe a method of analysing pharmacoMRI data using SPM and apply it to the direct i.v. infusion of selective 5-HT reuptake inhibitor, citalopram, in 12 healthy volunteers. Scanning took place on a 1.5-T Philips MRI scanner. RESULTS: Areas implicated in depression and its treatment were observed to have increasing signal with respect to time. These areas included the caudate, the amygdala, the hippocampus, the striatum and the thalamus. CONCLUSION: Direct pMRI using i.v. citalopram opens new ways of investigating 5-HT mechanism in depression and its treatment.
Authors: D Marazziti; A Rossi; G Giannaccini; K M Zavaglia; L Dell'Osso; A Lucacchini; G B Cassano Journal: Eur Neuropsychopharmacol Date: 1999-12 Impact factor: 4.600
Authors: H S Mayberg; S K Brannan; J L Tekell; J A Silva; R K Mahurin; S McGinnis; P A Jerabek Journal: Biol Psychiatry Date: 2000-10-15 Impact factor: 13.382
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Mark G Devlin; Nicola J Smith; Olivia M Ryan; Elizabeth Guida; Patrick M Sexton; Arthur Christopoulos Journal: Eur J Pharmacol Date: 2004-09-13 Impact factor: 4.432
Authors: Sakthivel Sekar; M Verhoye; J Van Audekerke; G Vanhoutte; Andrew S Lowe; Andrew M Blamire; Thomas Steckler; A Van der Linden; Mohammed Shoaib Journal: Psychopharmacology (Berl) Date: 2010-11-20 Impact factor: 4.530
Authors: Najmeh Khalili-Mahani; Serge A R B Rombouts; Matthias J P van Osch; Eugene P Duff; Felix Carbonell; Lisa D Nickerson; Lino Becerra; Albert Dahan; Alan C Evans; Jean-Paul Soucy; Richard Wise; Alex P Zijdenbos; Joop M van Gerven Journal: Hum Brain Mapp Date: 2017-02-01 Impact factor: 5.038
Authors: Arndis Simonsen; Jørgen Scheel-Krüger; Mads Jensen; Andreas Roepstorff; Arne Møller; Chris D Frith; Daniel Campbell-Meiklejohn Journal: Psychopharmacology (Berl) Date: 2014-01-25 Impact factor: 4.530